PubRank

M WEINER

Author PubWeight™ 22.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Metabolism of drugs in subjects with Laennec's cirrhosis. Med Exp Int J Exp Med 1959 1.38
2 Observations on the antirheumatic and physiologic effects of phenylbutazone (butazolidin) and some comparisons with cortisone. Am J Med 1954 1.22
3 Occurrence of fibrinolytic activity following administration of incotinic acid. Proc Soc Exp Biol Med 1959 1.18
4 The physiological disposition of dicumarol in man. J Pharmacol Exp Ther 1950 1.17
5 The biotransformation of ethyl biscoumacetate (tromexan) in man, rabbit and dog. J Pharmacol Exp Ther 1953 1.08
6 Relationship of platelet serotonin to disturbances of clotting and hemostasis. Circulation 1957 1.02
7 Production of steam volatile acids by bacteria-free Ascaris lumbricoides. J Infect Dis 1951 0.99
8 An evaluation of a new anticoagulant, acenocoumarin (sintrom). Circulation 1956 0.99
9 Metabolism of the chelating agent diethylenetriamine pentaacetic acid (C14DTPA) in man. Proc Soc Exp Biol Med 1962 0.97
10 A simply prepared, standardized, and relatively stable thromboplastin extract for estimation of prothrombin time. Am Heart J 1950 0.94
11 Observations on the metabolic transformation and effects of phenylbutazone in subjects with hepatic disease. Am J Med Sci 1954 0.91
12 The effect of water-soluble preparations of vitamin K in dicumarol-induced hypoprothrombinemia. N Engl J Med 1950 0.89
13 Influence of some vasoactive drugs on fibrinolytic activity. Circulation 1959 0.88
14 The influence of the physiologic disposition of chelates on their use in medicine. Ann N Y Acad Sci 1960 0.88
15 THE FIBRINOLYTIC RESPONSE TO NICOTINIC ACID IN ABNORMAL LIVER STATES. Am J Med Sci 1963 0.87
16 The control of prothrombin activity with tromexan therapy. Am J Med 1953 0.85
17 The physiological disposition of ethyl biscoumacetate (tromexan) in man and a method for its estimation in biological material. J Pharmacol Exp Ther 1952 0.84
18 Effect of starvation, acenocoumarin and vitamin K on the coagulation pattern of the guinea pig. Exp Med Surg 1959 0.82
19 The physiologic disposition of phenylindanedione in man. J Pharmacol Exp Ther 1954 0.81
20 Residual serum thrombin activity. Clin Chem 1958 0.78
21 Stimulus generalization as a function of verbal reinforcement combinations. J Exp Psychol 1954 0.77
22 Studies of coagulation and fibrinolysis by new technic of continuous recording. Blood 1955 0.76
23 The influence of barbiturates on coumarin plasma levels and prothrombin response. J Clin Invest 1961 0.75
24 Clot retraction and fibrinolysis. Clin Chem 1963 0.75
25 The dilution of plasma in estimating prothrombin activity. Acta Haematol 1950 0.75
26 Effects of training in space orientation on perception of the upright. J Exp Psychol 1955 0.75
27 The effects of differently structured visual fields on the perception of verticality. Am J Psychol 1955 0.75
28 An evaluation of methods of dicumarol administration. Am Heart J 1951 0.75
29 Ascorbic acid and blood coagulation. Ann N Y Acad Sci 1961 0.75
30 Hyperfibrinogenemia. Report of a case. JAMA 1962 0.75
31 Nonspecific factors in blood coagulation. J Lab Clin Med 1955 0.75
32 The response of hypoprothrombinemia in cirrhosis to vitamin K1 and K3. Am J Med Sci 1961 0.75
33 Dicumarol therapy. J Med Soc N J 1951 0.75
34 Microclotting techniques. J Lab Clin Med 1960 0.75
35 Estimation of prothrombin time. J Am Med Assoc 1948 0.75
36 Effect of environmental temperature upon clotting time of whole blood. Proc Soc Exp Biol Med 1948 0.75
37 Lability of fibrinolysin. Nature 1959 0.75
38 Investigation of coagulation defects using a modified prothrombin consumption test. Bull N Y Acad Med 1952 0.75
39 The perpetual chain around the neck of the Jew-his own self. Am Imago 1953 0.75
40 The diuretic action of a coumarin-mercurial compound. J Lab Clin Med 1950 0.75
41 Influence of fibrinogen concentration upon plasma prothrombin time. Blood 1949 0.75
42 Lack of effect of coenzyme Q10 on coumarin-induced hypoprothrombinaemia. Nature 1961 0.75
43 A comparative study of effects of coumarines by the use of a microprothrombin method. Exp Med Surg 1952 0.75
44 Clot firmness. Blood 1957 0.75
45 The effect of penicillin upon the coagulability of the blood. Exp Med Surg 1948 0.75
46 Platelet adhesiveness. Blood 1948 0.75
47 Afibrinogenemia occurring in a case of malignancy of the prostate with bone metastases. N Y State J Med 1949 0.75
48 THE SIGNIFICANCE OF THE PHYSIOLOGIC DISPOSITION OF DRUGS IN ANTICOAGULANT THERAPY. Semin Hematol 1964 0.75
49 Transitory variations in serum prothrombin activity. Proc Soc Exp Biol Med 1952 0.75
50 The clinical response in arthritis of long standing. Med Times 1950 0.75
51 Significance of clotting tests augmented by heparin. Am J Clin Pathol 1956 0.75
52 FACTORS INFLUENCING THE CLINICAL USE OF CHELATES IN IRON STORAGE DISEASE. Ann N Y Acad Sci 1964 0.75
53 PROBLEMS OF COOLEY'S ANEMIA: PANEL DISCUSSION. Ann N Y Acad Sci 1964 0.75
54 Coumarin anticoagulant agents. Trans Am Coll Cardiol 1952 0.75
55 Parahemophilia; Owren's disease. Pediatrics 1953 0.75
56 Ethyl butyrate hydrolyzing activity of human serum. Am J Clin Pathol 1950 0.75
57 DRUG-INDUCED INCREASE OF PROTHROMBIN COMPLEX ACTIVITY IN VIVO. Am J Med Sci 1964 0.75
58 The vitamin K tolerance test. Am J Clin Pathol 1948 0.75
59 Fate of dicumarol in man; relationship between prothrombin time and plasma levels of dicumarol. Bull N Y Acad Med 1949 0.75